13F-HR filed by Prescott General Partners LLC
Prescott General Partners LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 7 holding rows worth $1,801,801,573.
- Accession
- 0001104659-24-061917
- Filer
- CIK 1538653
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 7 entries on the cover page, a total value of $1,801,801,573 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,801,801,573 with VALUE read as dollars as filed, 13F file number 028-14951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CREDIT ACCEP CORP MICH | 225310101 | COM | 1,560,014 | $860,425,722 | dollars as filed | |
| CIMPRESS PLC | G2143T103 | SHS EURO | 3,906,492 | $345,763,607 | dollars as filed | |
| WORLD ACCEP CORPORATION | 981419104 | COM | 2,037,495 | $295,396,025 | dollars as filed | |
| WAYFAIR INC | 94419L101 | CL A | 3,823,239 | $259,521,463 | dollars as filed | |
| YELP INC CL A | 985817105 | Stock | 918,446 | $36,186,772 | dollars as filed | |
| LINEAGE CELL THERAPEUTICS IN | 53566P109 | COMMON STOCK | 1,851,851 | $2,740,739 | dollars as filed | |
| HUMACYTE INC | 44486Q103 | COM | 568,246 | $1,767,245 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-061917 | this filing | 2024-05-15 | acceptance time not in the bulk data set |